Search Results
HT-SPR Technology | High-Throughput Antibody Screening | Biology Solutions | LSA Platform
Carterra LSA Overview | HT-SPR | Biotechnology | High-res Epitope Binning | Antibody Screening
High Quality Therapeutic Antibodies | High-Throughput Antibody Screening | HT-SPR | LSA Platform
High res epitope binning | Antibody screening | High-Throughput Antibody Screening | LSA Platform
Therapeutic Antibody Screening in Post Genomics Era | HT-SPR | Carterra LSA Platform | Biotech
Accelerating Discovery of Therapeutic Antibodies Using HT-SPR | Biology Solutions | LSA Platform
AET Europe 2023: The new Carterra LSA-XT and HT-SPR characterization of multi-specific antibodies
Improve Therapeutic Antibody Screening | Leverage HT-SPR to Complement AlphaLISA | LSA Platform
Carterra CSO Speaks at Sept 2018 Seminar | Monoclonal Antibody (mAb) | HT-SPR | LSA Platform
HT-SPR Transcendence Technology | #1 Discovery Platforms | Time To Clinic Impact | LSA Platform
HT-SPR Technology Across Discovery Platforms | Therapeutic Antibody Screening | Novel Therapeutics
Screen biotherapeutic targets using Carterra's software suite | High-Throughput Antibody Screening
